| Literature DB >> 30414264 |
Dikonketso Shirley-May Matjuda1, Olayinka Ayobami Aiyegoro1.
Abstract
Management and disposal of pig farm seepage constitute a serious environmental challenge, and seepage discharge from agricultural waste-water is considered to be one of the greatest contributors of organic substances, bacterial pathogens, and antibiotic resistance genes into the environment. The objectives of this study were to assess the level of bacteriological pollution and to identify the resident antibiotic-resistant genes of culturable bacteria from a studied pig farm seepage. Enumeration of the viable bacterial cell of plated bacteria suspensions (10-1 to 10-8 cfu/mL) was performed; also, identification of pure bacterial colonies was done using an API 20E bacterial identification kit. CLSI guidelines for antimicrobial susceptibility testing were adopted to determine the antibiotic susceptibility/resistance of the cultured bacterial isolates. Identification of resident-resistant genes was done using molecular biology procedures. The results on viable cells in seepage samples ranged from 4.30 × 102 to 1.29 × 109 cfu/mL. Pseudomonas luteola, Enterococcus vulneris, Salmonella choleraesuis spp arizonae, Escherichia coli, Enterobacter cloacae, Proteus mirabillis etc. were isolated from the pig farm soil samples. Almost all of the cultured isolates were resistant to Penicillin G, Vancomycin, Oxytetracycline, Spectinomycin, and Lincomycin. The most frequent resistant genes detected in the isolates were Van A, Van B, InuA, aph (3")-llla, blaTEM, Otr A, and Otr B. It was inferred from the study that Pig farm seepage has the ability to cause bacterial pollution that may negatively impact the natural environment, by introducing bacteria pathogens that harbor antibiotic-resistant genes.Entities:
Keywords: Seepage; antibiotics; bacteria; pig farm; pollution; resistance gene
Mesh:
Substances:
Year: 2018 PMID: 30414264 PMCID: PMC6528592 DOI: 10.1002/mbo3.737
Source DB: PubMed Journal: Microbiologyopen ISSN: 2045-8827 Impact factor: 3.139
Primer sequence and annealing temperature for detection of antibiotic resistance genes
| Primers | Sequence (5' to 3') | Annealing Temperature | Type of resistance mediated | References |
|---|---|---|---|---|
|
|
| 53°C | Plasmid mediated (aminoglycoside resistance) | Vakulenko et al. ( |
|
|
| 55°C | Vakulenko et al. ( | |
|
|
| 58°C | Vakulenko et al. ( | |
|
|
| 58°C | Vakulenko et al. ( | |
|
|
| 56°C | Vakulenko et al. ( | |
|
|
| 54°C | Vakulenko et al. ( | |
|
|
| 58°C | Vakulenko et al. ( | |
|
|
| 55°C | Vakulenko et al. ( | |
|
|
(F)CAT GAA TAG AAT AAA AGT TGC AAT A | 55°C | Chromosomal mediated (glycopeptide: vancomycin resistance) | Jánošková & Kmeť ( |
|
|
(F)GTG ACA AAC CGG AGG CGA GGA | 58°C | Jánošková & Kmeť ( | |
|
|
(F)GGT ATC AAG GAA ACC TC | 54°C | Jánošková & Kmeť ( | |
|
|
(F) CGG GGA AGA TGG CAG TAT | 55°C | Jánošková & Kmeť ( | |
|
|
(F) GAACACGTACTGACCGAGAAG | 57°C | Ribosomal mediated (Oxytetracycline resistance) | Nikolakopoulou et al. ( |
|
|
(F) CCGACATCTACGGGCGCAAGC | 61°C | Efflux mediated (Oxytetracycline resistance) | Nikolakopoulou et al. ( |
|
|
(F) ATGCGTTATATTCGCCTGTG | 53°C | Extended‐spectrum β‐lactamases resistance (Ceftazidime) | Jiang et al. ( |
|
|
(F) ATGAGTATTCAACATTTTCG | 47°C | Strateva et al. ( | |
|
|
(F) CGAGCGCCAGTGCATCAAC | 56°C | Strateva et al. ( | |
|
|
(F) CGACTTCCATTTCCCGATGC | 55°C | Strateva et al. ( | |
|
|
(F) AATTTGGGCTTAGGGCAGAA | 45°C | Strateva et al. ( | |
|
|
| 62°C | Sulfonamide resistance | Faldynova et al. ( |
|
|
F'‐5' CGCAATGTGATCCATGATGT'3 | 60°C | Faldynova et al. ( | |
|
|
(F) GGTGGCTGGGGGGTAGATGTATTAACTGG | 56°C | Chromosomal mediated (Lincomycin resistance) | Li et al. ( |
|
|
(F) CCTACCTATTGTTTGTGGAA | 50°C | Li et al. ( | |
|
|
(F) AATTTGCAATAGATGCGGAGA | 52°C | Li et al. ( | |
|
|
(F) ACGGAGGGATCACATGGTAA | 55°C | Li et al. ( | |
|
|
(F) CACCATGCTTCAGCAGAAAATGATC | 55°C | Li et al. ( |
Thermal cycling protocol for detection of ARG's
| Cycle step | Temperature | Time | Number of cycles |
|---|---|---|---|
| Initial denaturing | 98°C | 30 s | 1 |
| Denaturing | 98°C | 10 s | 35 |
| Annealing | The annealing temperature of Primer (Table | 30 s | |
| Extension | 72°C | 30 s | |
| Final extension | 72°C | 10 min | 1 |
Figure 1Results for bacteriological analyses of pig farm water samples on Nutrient agar. Key: WW‐Enc = enclosure water; Iff‐WW = influent 2 m away from constructed wetland; WW‐CW1 = constructed wetland 1; WW‐CW2 = construction wetland 2; WW‐Eff = effluent 2 m away from constructed wetland
Figure 2Results for Bacteriological analyses of pig farm water samples on EMB agar. Key: WW‐Enc = enclosure water; Iff‐WW = influent 2 m away from constructed wetland; WW‐CW1 = constructed wetland 1; WW‐CW2 = construction wetland 2; WW‐Eff = effluent 2 m away from constructed wetland
Figure 3Results for Bacteriological analyses of pig farm water samples on XLD agar. Key: WW‐Enc = enclosure water; Iff‐WW = influent 2 m away from constructed wetland; WW‐CW1 = constructed wetland 1; WW‐CW2 = construction wetland 2; WW‐Eff = effluent 2 m away from constructed wetland
Figure 4Results for bacteriological analyses of pig farm water samples on MacConkey agar. Key: WW‐Enc = enclosure water; Iff‐WW = influent 2 m away from the constructed wetland; WW‐CW1 = constructed wetland 1; WW‐CW2 = construction wetland 2; WW‐Eff = effluent 2 m away from the constructed wetland
Figure 5Results of susceptibility analyses of 18 different antibiotics used to test antibiotic sensitivity in isolates. Penicillin G (P), Sulphamethaxazole (RL), Vancomycin (VA), Ampicillin (AML), Amoxicillin (APR), Apramycin (AMP), Neomycin (N), Tilmicosin (TIL), Oxytetracycline (OT), Spectinomycin (SH), Lincomycin (MY), Trimethoprim (TM). Nitrofurantoin (NI), Nalidixic Acid (NA), Norfloxacin (NOR), Oxytetracycline (OT), Tetracycline (TE), Gentamicin (CAZ), Ceftazidime (CN)
The predominant multiple antibiotic resistance phenotypes and multidrug‐resistant Index of isolates
| Multiple antibiotic resistance phenotype (MARP) | Multidrug‐resistant index (MDRI) | |||||
|---|---|---|---|---|---|---|
| Phenotype | Number(s) of Isolates | Percentage (%) | Isolates | MDRI (%) | Isolates | MDRI (%) |
| VA‐SH‐TM | 2 | 10.50 | EFF4a | 100 | CW1–3 | 83 |
| SH‐MY‐TM | 2 | 10.50 | EFF6 | 100 | IFF4 | 25 |
| RL‐APR‐TIL‐SH‐MY‐TM | 2 | 10.50 | EW8 | 100 | IFF5 | 25 |
| P‐VA‐TIL‐OT‐SH‐MY | 2 | 10.50 | EW1 | 100 | IFF6 | 83 |
| P‐RL‐VA‐TIL‐OT‐SH‐MY | 2 | 10.50 | EW1 | 75 | IFF7 | 25 |
| P‐RL‐VA‐APR‐TIL‐OT‐MY | 2 | 10.50 | EW10 | 58 | IFF9 | 92 |
| P‐RL‐VA‐APR‐N‐TIL‐OT‐SH‐MY | 6 | 31.60 | EFF3 | 100 | IFF8 | 58 |
| P‐RL‐VA‐APR‐AMP‐N‐TIL‐OT‐SH‐MY‐TM | 3 | 17.80 | EW14 | 75 | IFF1 | 75 |
| P‐RL‐VA‐AML‐APR‐AMP‐TIL‐OT‐SH‐MY‐TM | 3 | 17.80 | EW11 | 75 | IFF20 | 83 |
| P‐RL‐VA‐AML‐APR‐AMP‐TIL‐OT‐SH‐MY | 4 | 21.05 | EW12 | 67 | IFF3 | 42 |
| P‐RL‐VA‐AML‐APR‐AMP‐OT‐SH‐MY‐TM | 2 | 10.50 | EW9 | 75 | ||
| P‐RL‐VA‐AML‐APR‐AMP‐N‐TIL‐OT‐SH‐MY‐TM | 15 | 78.95 | EW7 | 100 | ||
| P‐RL‐VA‐AML‐APR‐AMP‐N‐TIL‐OT‐SH‐MY | 4 | 21.05 | EFF2 | 100 | ||
| P‐RL‐VA‐AML‐AMP‐TIL‐OT‐SH‐MY‐TM | 2 | 10.50 | EFF5 | 100 | ||
| P‐RL‐VA‐AML‐AMP‐SH‐MY‐TM | 2 | 10.5 | EFF15 | 100 | ||
| P‐RL‐VA‐AML‐AMP‐N‐TIL‐OT‐SH‐MY | 2 | 10.50 | EFF1 | 92 | ||
| P‐AML‐AMP‐OT‐SH‐TM | 2 | 10.50 | EW3 | 75 | ||
| OT | 2 | 10.50 | EFF4 | 100 | ||
| MY | 2 | 10.50 | EW2 | 83 | ||
The table shows the most occurring phenotype antibiotic‐resistant patterns and shows isolates with the highest MDIR where 10 isolates showed 100% MDRI. Isolate had up to 19 phenotypes multiple resistance. Most isolates had predominant P‐RL‐VA‐AML‐APR‐AMP‐N‐TIL‐OT‐SH‐MY‐TM (78.95%), and P‐RL‐VA‐APR‐N‐TIL‐OT‐SH‐MY (31.60%) phenotype multiple resistance. About 55 isolates had more than five phenotype antibiotic resistance patterns where Penicillin G (P), Sulphamethaxazole (RL), Vancomycin (VA), Ampicillin (AML), Tilmicosin (TIL), Oxytetracycline (OT), Spectinomycin (SH), Lincomycin (MY) were the most predominant.
Results for detection of resistance genes in isolate
| Isolates | Antibiotic resistance genes | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| − | − | − | − | − | − | − | + | + | − | + | − | − | − | + | − | − | + | − | − | − | + | − | + | − | − | − |
|
| + | + | + | + | − | − | − | + | + | − | − | − | + | ‐ | − | − | − | + | − | + | − | + | + | + | − | − | − |
|
| − | + | − | − | − | + | − | + | + | − | + | + | − | − | − | − | − | − | − | + | − | − | + | + | + | + | + |
|
| − | − | − | − | + | − | − | + | + | − | − | − | − | − | − | − | − | − | + | + | − | + | + | + | − | − | + |
|
| − | − | + | + | − | + | − | + | + | + | + | − | + | − | − | − | − | − | − | + | − | − | + | + | + | − | − |
|
| − | − | − | − | − | − | − | + | + | − | + | − | − | − | − | − | − | + | − | − | − | + | + | + | − | − | − |
|
| − | − | + | − | − | + | − | + | + | − | + | − | + | − | + | − | − | + | − | − | − | − | + | + | + | + | + |
|
| − | − | + | − | − | − | − | − | + | − | + | − | − | − | − | − | − | − | + | − | − | + | + | + | − | − | + |
|
| − | + | − | − | − | − | − | + | + | − | + | − | + | − | + | − | − | + | − | + | − | − | + | − | − | − | + |
|
| − | + | + | + | − | + | − | − | − | − | − | − | + | − | + | − | − | − | − | − | − | + | + | + | − | + | − |
|
| − | − | − | − | − | + | − | − | + | − | + | − | − | − | − | − | − | − | − | + | − | − | + | − | − | − | + |
|
| − | + | − | − | − | + | − | + | + | − | + | − | + | − | + | − | + | − | − | − | − | + | − | + | + | − | + |
|
| + | − | − | − | − | + | − | + | + | − | − | − | + | − | − | − | + | + | − | − | − | − | + | + | − | − | − |
|
| − | + | + | − | − | + | − | + | + | − | + | − | + | − | + | − | + | + | + | − | − | − | + | + | − | + | + |
|
| − | − | − | − | − | + | − | + | + | + | − | − | − | − | + | + | − | + | − | − | − | + | + | + | − | − | + |
|
| − | + | − | − | − | + | − | + | + | − | + | − | + | − | − | − | − | − | − | − | − | − | + | + | − | − | − |
|
| − | − | + | − | − | + | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − |
| 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | 17 | |
| Total number of isolate possessing tested ARG | 2 | 7 | 7 | 3 | 1 | 11 | 0 | 13 | 15 | 2 | 11 | 1 | 9 | 0 | 7 | 1 | 3 | 8 | 3 | 6 | 0 | 8 | 14 | 14 | 4 | 4 | 9 |
+: Antibiotic resistant gene detected; −: no antibiotic resistance gene detected; ARG: antibiotic resistance gene.
Results for detection of resistance genes in isolate (Continue)
| Isolates | Antibiotic resistance genes | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| − | − | − | − | − | − | − | + | + | − | + | − | + | − | + | − | − | − | − | + | − | + | + | + | − | − | + |
|
| − | + | − | − | − | + | − | − | − | − | − | − | − | − | + | − | + | + | − | − | − | − | − | − | − | + | + |
|
| − | − | − | − | − | − | − | + | + | − | + | − | + | − | − | − | − | + | − | − | − | − | + | − | − | − | + |
|
| + | + | + | − | − | + | − | − | − | − | − | − | + | − | + | − | + | − | − | − | − | − | − | − | − | + | |
|
| − | − | + | − | − | + | − | − | + | + | − | − | + | − | − | − | + | + | − | − | − | − | + | − | − | + | − |
|
| − | − | + | − | − | + | − | − | − | − | − | − | + | + | − | − | − | − | − | − | − | − | + | + | + | − | − |
|
| − | − | + | − | − | + | − | + | + | − | − | − | + | − | − | − | − | + | + | − | − | − | + | + | − | + | + |
|
| − | + | − | − | − | + | − | − | + | − | + | − | − | − | + | − | − | − | − | − | − | − | − | − | + | + | − |
|
| − | − | − | − | − | + | − | + | + | − | − | − | − | + | + | − | + | + | − | − | − | + | + | + | − | + | − |
|
| − | − | − | − | − | + | − | + | + | + | + | − | + | − | − | − | − | − | + | − | − | − | + | + | − | + | + |
|
| − | + | + | − | − | + | − | + | + | − | − | − | − | + | + | − | − | + | + | − | − | − | + | + | + | + | + |
|
| − | − | + | + | − | − | − | + | + | − | + | − | − | − | − | − | − | − | − | − | − | + | + | + | + | − | − |
|
| − | + | − | + | − | − | − | + | + | − | + | − | − | − | − | + | + | + | − | − | − | + | + | + | − | − | − |
|
| − | − | − | − | − | + | − | + | + | − | − | − | + | − | − | − | − | + | − | − | − | − | + | + | + | − | + |
|
| − | − | − | − | − | + | − | + | + | − | + | − | + | + | − | − | − | + | − | − | − | − | + | − | − | + | − |
|
| − | − | − | − | − | + | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | − | + | − |
|
| − | + | + | − | − | + | − | − | − | − | − | − | − | − | + | − | − | − | − | + | − | − | + | − | − | − | − |
|
| − | + | + | + | − | + | − | − | − | − | − | − | + | − | + | − | − | − | − | − | − | + | − | + | + | − | − |
| Number of isolates tested | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 | 18 |
| Total number of isolate possessing tested ARG | 1 | 7 | 8 | 3 | 0 | 14 | 0 | 10 | 12 | 2 | 7 | 0 | 10 | 4 | 8 | 1 | 4 | 10 | 2 | 1 | 0 | 5 | 13 | 10 | 6 | 9 | 8 |
+: Antibiotic resistant gene detected; −: no antibiotic resistance gene detected; ARG: antibiotic resistance gene.